Catalyst Wire Dossier Catalyst Wire Dossier

Dexamethasone sodium phosphate (intra-erythrocyte formulation)

Dexamethasone sodium phosphate · Quince Therapeutics S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dexamethasone sodium phosphate (intra-erythrocyte formulation), covering 2024-10-10 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients [Phase 2]

See pricing